首页> 外文期刊>Journal of cataract and refractive surgery >Zernike versus Fourier treatment tables for myopic patients having CustomVue wavefront laser in situ keratomileusis with the S4 excimer laser.
【24h】

Zernike versus Fourier treatment tables for myopic patients having CustomVue wavefront laser in situ keratomileusis with the S4 excimer laser.

机译:Zernike与Fourier治疗台,适用于具有CustomVue波前激光和S4准分子激光原位角膜磨镶术的近视患者。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To compare the efficacy, predictability, and safety of Zernike-based versus Fourier-based treatment tables in myopic eyes 1 year after CustomVue wavefront laser in situ keratomileusis (LASIK) using the S4 excimer laser (Visx). SETTING: Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA. METHODS: A prospective analysis of 32 eyes of 16 patients with myopia who had CustomVue LASIK with the S4 excimer laser was conducted using Zernike or Fourier treatment tables. Mean spherical equivalent (SE), uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), and higher wavefront analyses were determined. RESULTS: The mean postoperative SE was -0.27 diopter (D) +/- 0.41 (SD) in Zernike-treated eyes and -0.20 +/- 0.29 D in Fourier-treated eyes. Twenty-eight of 32 eyes were available for analysis. Ninety-two percent of eyes in the Zernike group and all eyes in the Fourier group had 20/20 or better acuity (P = .85). Seventy-nine percent and92%, respectively, were within +/-0.50 D of emmetropia (P = .68). All eyes in the Zernike group and 93% of eyes in the Fourier group had no change or gained at least 1 Snellen line of BSCVA (P = .85). Mean higher-order aberration values (mum) in the Zernike group and Fourier group were as follows: total root mean square, 0.91 and 0.99, (P = 0.95); defocus, 0.71 and 0.74, (P = 0.98); astigmatism, 0.15 and 0.31, (P = 0.81); coma, 0.21 and 0.20, (P = 0.99); trefoil, 0.11 and 0.11, (P = 1); and spherical aberration, 0.17 and 0.30, (P = 0.85), respectively. CONCLUSIONS: Myopic eyes that had CustomVue LASIK had better visual outcomes in the Fourier group than in the Zernike group. Higher-order wavefront aberration results were similar between the 2 groups.
机译:目的:比较使用S4准分子激光(Visx)对CustomVue波前激光原位角膜磨镶术(LASIK)治疗一年后近视眼中基于Zernike和基于Fourier的治疗台的疗效,可预测性和安全性。地点:美国加利福尼亚州斯坦福市,斯坦福大学医学院眼科。方法:使用Zernike或Fourier治疗台对16例患有CustomVue LASIK的近视眼患者使用S4准分子激光进行前瞻性分析,共16眼。确定了平均球当量(SE),未矫正视力(UCVA),最佳眼镜矫正视力(BSCVA)和更高的波前分析。结果:Zernike治疗眼的平均术后SE为-0.27屈光度(D)+/- 0.41(SD),Fourier治疗眼的平均SE为-0.20 +/- 0.29D。 32只眼中有28只可用于分析。 Zernike组的92%的眼睛和Fourier组的所有眼睛的视力达到20/20或更高(P = .85)。 79%和92%分别在正视眼的+/- 0.50 D以内(P = .68)。泽尼克(Zernike)组的所有眼睛和傅立叶(Fourier)组的93%的眼睛无变化或至少获得1条SSC的Snellen线(P = .85)。泽尼克(Zernike)组和傅里叶(Fourier)组的平均高阶像差值(mum)如下:总均方根分别为0.91和0.99,(P = 0.95);离焦0.71和0.74(P = 0.98);散光分别为0.15和0.31(P = 0.81);昏迷0.21和0.20(P = 0.99);三叶,0.11和0.11,(P = 1);球差分别为0.17和0.30(P = 0.85)。结论:具有CustomVue LASIK的近视眼在傅立叶组中的视觉效果比在Zernike组中更好。两组之间的高阶波前像差结果相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号